Background. Many effects of adenosine on renal function have been iden
tified. The development of adenosine receptor blockers has made it pos
sible to identify which of these effects are exerted by endogenous ade
nosine. At least four adenosine receptor subtypes, denoted A(1), A(2a)
, A(2b), and A(3) are currently known. In the present study the select
ive A(1) receptor blocker 1,3-dipropyl-8 [2-(5,6-epoxy) norbanyl] xant
hine (CVT-117) was used to assess the effect of A(1) activation by end
ogenous adenosine on renal function in rats. Methods. Clearance studie
s were performed before and after administration of 0.1 mg/kg and 0.8
mg/kg of CVT-117 in separate groups of rats and before and after admin
istration of vehicle in time-control rats. Measurements of heart rate
before and after administration of exogenous adenosine confirmed effec
tive A(1) receptor blockade. Results. At both the lower and higher dos
es, A(1) receptor blockade with CVT-117 increased fractional sodium ex
cretion and urine flow rate without altering GFR. The increase in sodi
um excretion following A(1) blockade was not accompanied by increases
in the excretion of phosphate or potassium. Conclusion. These results
show that endogenous adenosine promotes sodium retention by activation
of A(1) receptors.